Clarity over comfort.
Say it while it's still a problem to solve, not a verdict to deliver.
CEO. OPERATOR. AUTHOR.
I help MedTech companies close the gap between a product that works and a business that grows. Two decades in the field. No sugarcoating.
EXPERIENCE. NOT THEORY.
Pittsburgh. Father of four.
At home on the water and on skis.
My first launch, I didn't really know what I was doing. Thirty brands later, I know what separates a good clinical story from a real commercial business.
I've launched drugs, devices, combination products and software. I've integrated a $275M acquisition, rehabilitated a $1B brand, and worked on both the founding and funding sides of the table.
Today, I'm CEO and Board Director of NightWare and President of Breakthrough MedTech Strategy. I take the commercial seat, not the sidelines.
Say it while it's still a problem to solve, not a verdict to deliver.
Real launches. Real customers. Lessons learned carrying the bag.
Position for what the market will reward next. Execute today.
CURRENTLY / LEADING NIGHTWARE
NightWare is an FDA-cleared prescription digital therapeutic for PTSD-related nightmares. I built its commercial function from $0 to $7.5M, with Department of Defense adoption along the way. In June 2024, I became CEO to lead a strategic and financial reset.
Visit NightWare ↗BREAKTHROUGH MEDTECH STRATEGY
The gap between “this works” and “hospitals pay for this, repeatedly” is where good companies get stuck. Closing that gap is what I do.
Build the commercial foundation before you build the sales team. Customer insight, clinical utility, evidence, brand and a focused strategy your team can actually execute.
I take the seat, not the sidelines. Sales design and compensation, contracting, marketing, payer access and enablement—until you know exactly what full-time hire you need.
Build a commercial story that survives diligence. I've integrated acquisitions from the buy side and advised ten premarket products, including a client exit to Integra LifeSciences.
FOR BOARDS, INVESTORS & CEOS
An independent operator's view of where the commercial plan is breaking. Scoped around a decision, not a calendar.
SELECTED OUTCOMES
REAL EXPERIENCE. ON THE PAGE.
No theory. Real board meetings, real numbers, and the questions that matter when the plan isn't working.
2026 / FOR BOARDS, INVESTORS & CEOS
What MedTech boards and investors see, don't say, and pay for later.
I wrote it for the person who wrote the check, and for the CEO who knows the plan isn't working. It's the operator's view of governance under stress—and a way to raise the hard question without losing the CEO.
The fastest way to find out whether the way I think is useful to you.
Practical board diagnostics and an operator's perspective on the conversations that can't wait.
KEYNOTES. PANELS. REAL CONVERSATIONS.
No buzzwords. No hype. Real launches, real board meetings, and frameworks your audience can run on Monday morning.
The Ten MedTech Commandments: what decides whether a product gets adopted or shelved.
Nobody Wants to Say It: how boards raise hard questions without losing the CEO.
The Selfish Career: goals, leverage, and skills that outlast any employer.
SPECIFIC QUESTIONS. HONEST ANSWERS.
Consulting, NightWare, books or speaking. Give me enough detail for a real answer instead of a “tell me more.”
[email protected] ↗“A hard truth beats a soft lie.”— MATT TUCKER